VYNE Therapeutics
VYNE
VYNE
41 hedge funds and large institutions have $3.25M invested in VYNE Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% less capital invested
Capital invested by funds: $5.63M → $3.25M (-$2.38M)
Holders
41
Holding in Top 10
–
Calls
$28K
Puts
–
Top Buyers
| 1 | +$125K | |
| 2 | +$50K | |
| 3 | +$45K | |
| 4 |
Citigroup
New York
|
+$15.5K |
| 5 |
VF
Virtu Financial
New York
|
+$15.5K |
Top Sellers
| 1 | -$154K | |
| 2 | -$91K | |
| 3 | -$73.8K | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$65K |
| 5 |
BlackRock
New York
|
-$43.9K |